SCHEMBL17614546

SCHEMBL17614546

CCc1ccc(-c2cccc(OCc3c(C)cccc3-n3nnn(C)c3=O)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 3/20 0.39
PTGER4 P35408 2/20 0.36
NR1H4 Q96RI1 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
FFAR1 O14842 1/20 0.36
MRGPRX4 Q96LA9 2/20 0.35
DHODH Q02127 3/20 0.35
SLC13A5 Q86YT5 2/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
THRB P10828 1/20 0.34
SOD1 P00441 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
XBP1 P17861 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16206150 0.91 SLC22A12 (0.41) SLC22A12PTGER4NR1H4RXRARXRB
SCHEMBL16205967 0.91 SLC22A12 (0.42) SLC22A12PTGER4NR1H4RXRARXRB
SCHEMBL17614547 0.89 PTGER4 (0.40) SLC22A12PTGER4NR1H4FFAR1DHODH
SCHEMBL16206147 0.89 SLC22A12 (0.40) SLC22A12PTGER4NR1H4RXRARXRB
SCHEMBL17614551 0.89 MRGPRX4 (0.43) SLC22A12PTGER4NR1H4RXRARXRB
SCHEMBL17614548 0.88 SLC22A12 (0.42) SLC22A12PTGER4FFAR1TP53ALDH1A1
SCHEMBL16206146 0.88 SLC22A12 (0.42) SLC22A12PTGER4NR1H4FFAR1GAA
SCHEMBL17615157 0.88 PPARD (0.38) SLC22A12PTGER4DHODH
SCHEMBL17614549 0.87 SLC22A12 (0.39) SLC22A12PTGER4NR1H4RXRARXRB
SCHEMBL17615154 0.87 SLC22A12 (0.39) SLC22A12PTGER4NR1H4RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9867372-B2 Tetrazolinone compound and use of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-16 US disclosed
US-9867372-B2 Tetrazolinone compound and use of same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-16 US disclosed
US-20160081339-A1 TETRAZOLINONE COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-24 US disclosed
US-20160081339-A1 TETRAZOLINONE COMPOUND AND USE OF SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160081339-A1 TETRAZOLINONE COMPOUND AND USE OF SAME MT-CO1, SOD1, MT-CO2 SLC22A12 3344/4885PTGER4 2169/4885NR1H4 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.